Drug Trial Radar · NCT07442877
A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic Surgery
Last checked: Nov 20, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
161
Actual
Start
Sep 13, 2024
Primary completion
Jan 24, 2025
Study completion Jan 24, 2025
Sponsor
- Lead sponsor
- Haisco Pharmaceutical Group Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Mar 2, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 74 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, randomized, double-blind, placebo/active-controlled study. 160 subjects undergoing orthopedic surgery under general anesthesia are planned to be enrolled and randomized into the HSK21542 group, morphine group, and placebo group.
Conditions
- Postoperative Pain Management
Interventions
HSK21542 dose level 1Drug
Patients administrated with HSK21542 dose level 1
HSK21542 dose level 2Drug
Patients administrated with HSK21542 dose level 2
PlaceboDrug
Patients administrated with placebo
morphineDrug
Patients administrated with morphine
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sum of Pain Intensity Differences (SPID)Time frame: 48 hours
Locations
27 sites in 1 country. Site status is shown where the registry gives one.
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, China
Huashan Hospital, Fudan University
Shanghai, China
Shenzhen Second People's Hospital
Shenzhen, China
The First Affiliated Hospital of USTC (Anhui Provincial Hospital)
Hefei, Anhui, China
The Third Affiliated Hospital, Southern Medical University
Guangzhou, Guangdong, China
Liuzhou People's Hospital
Liuzhou, Guangxi, China
Hebei Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine
Cangzhou, Hebei, China
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
The Third Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
The Fourth Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
The Second Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Yichang Central People's Hospital (Wujia Campus)
Yichang, Hubei, China
Yichang Central People's Hospital (Xiling Campus)
Yichang, Hubei, China
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China
Xiangya Hospital of Central South University
Changsha, Hunan, China
Huai'an Second People's Hospital
Huaian, Jiangsu, China
Nanjing First Hospital
Nanjing, Jiangsu, China
Zhongda Hospital, Southeast University
Nanjing, Jiangsu, China
Wuxi People's Hospital
Wuxi, Jiangsu, China
Ganzhou People's Hospital
Ganzhou, Jiangxi, China
The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital)
Jinan, Shandong, China
Mianyang Central Hospital
Mianyang, Sichuan, China
Mianyang Orthopedic Hospital
Mianyang, Sichuan, China
Suining Central Hospital
Suining, Sichuan, China
Huzhou Central Hospital
Huzhou, Zhejiang, China
Jinhua Central Hospital
Jinhua, Zhejiang, China
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.